Join
Live feed
·
PRReleasevia Quantisnow
Cellect Biotechnology Ltd. logo

Cellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.

ByQuantisnow·Wall Street's wire, on your screen.
APOP· Cellect Biotechnology Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APOP (Cellect Biotechnology Ltd.) and more on Quantisnow.